-------------------------------------------
OMB APPROVAL
-------------------------------------------
OMB Number: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form................... 14.90
-------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
BIO-TECHNOLOGY GENERAL CORP.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
090578-10-5
(CUSIP Number)
Emanuel J. Adler, Esq.
Tenzer Greenblatt LLP
405 Lexington Avenue
New York, New York 10174
(212) 885-5000
(Name, Address and Telephone Number of Person Authorized to Receive Notice
and Communications)
September 13, 1996
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box |_|.
Check the following box if a fee is being paid with the statement|_|. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 7 Pages
<PAGE>
CUSIP No. 090578-10-5 Page 2 of 7 Pages
SCHEDULE 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MOSES MARK
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 2,097,129
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH ---
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 2,097,129
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
---
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,097,129
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.7%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 2 of 7 Pages
<PAGE>
CUSIP No. 090578-10-5 Page 3 of 7 Pages
SCHEDULE 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
UNITED EQUITIES (COMMODITIES) COMPANY
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 1,092,890
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH ---
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 1,092,890
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
---
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,092,890
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.5%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN, BD
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 3 of 7 Pages
<PAGE>
CUSIP No. 090578-10-5 Page 4 of 7 Pages
SCHEDULE 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MOMAR CORP.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [X]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
N/A
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
MARYLAND
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 1,000,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH ---
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 1,000,000
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
---
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,000,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.2%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO, HC
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
Page 4 of 7 Pages
<PAGE>
This Amendment No. 1 amends and supplements the Schedule 13D, dated October
14, 1994 (the "Schedule 13D"), of Moses Marx, United Equities (Commodities)
Company ("United Equities Commodities") and Momar Corp. ("Momar") (the
"Reporting Persons"), with respect to the Common Stock, par value $.01 per share
(the "Common Stock"), of Bio-Technology General Corp. (the "Company"). Except as
modified hereby, there has been no change in the information previously reported
in the Schedule 13D.
Item 5. Interest in Securities of the Issuer.
(a)-(b) According to the Company's Quarterly Report on Form 10-Q for the
period ended June 30, 1996, there were outstanding 44,504,547 shares of Common
Stock on August 9, 1996.
Moses Marx
Moses Marx beneficially owns 2,097,129 shares of Common Stock, comprising 4.7%
of the issued and outstanding shares of the Common Stock, including (i) 4,239
shares (.0095%) owned directly by Mr. Marx; (ii) 1,092,890 shares (2.5%) owned
of record by United Equities Commodities; and (iii) 1,000,000 shares (2.2%)
owned of record by Momar, of which, with respect to the shares described in
clauses (ii) and (iii), Mr. Marx may be deemed to be a beneficial owner by
virtue of his being the only person in a position to determine the investment
and voting decisions of United Equities Commodities and Momar with respect to
such shares.
Mr. Marx has the sole power to vote and dispose of all such shares.
United Equities Commodities
United Equities Commodities owns 1,092,890 shares of Common Stock, comprising
2.5% of the issued and outstanding shares of the Common Stock.
Momar
Momar owns 1,000,000 shares of Common Stock, comprising 2.2% of the issued and
outstanding shares of the Common Stock.
Page 5 of 7 Pages
<PAGE>
(c)(i) During the past 60 days, United Equities Commodities made the
following sales of shares of Common Stock in open market transactions on the
NASDAQ Small Cap Market:
No. of Price
Date Shares Sold Per share
---- ----------- ---------
08/21/96 80,000 $8.375
08/21/96 20,000 $8.50
08/21/96 20,000 $8.625
08/22/96 25,000 $8.750
08/22/96 25,000 $8.875
08/22/96 25,000 $9.00
08/22/96 25,000 $9.125
08/28/96 25,000 $9.625
(ii) On September 13, 1996, United Equities Commodities donated
200,000 shares of Common Stock to Terumah Foundation, a 501(c)(3) tax exempt
organization.
(iii) On September 30, 1996, Mr. Marx was issued 314 shares of Common
Stock pursuant to the Company's Stock Compensation Plan.
Other than as set forth above in Item 5(c), the Reporting Persons have not
effected any transactions in the Common Stock in the last 60 days.
(d) The Reporting Persons affirm that no person other than the Reporting
Persons have the right to receive or the power to direct the receipt of
dividends from, or the proceeds from the sale of, the shares of Common Stock
beneficially owned by them.
(e) On September 13, 1996, the Reporting Persons ceased to be the owners of
more than five percent (5%) of the shares of Common Stock of the Company.
Page 6 of 7 Pages
<PAGE>
SIGNATURE
---------
After reasonable inquiry, and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Date: October 21, 1996
/s/ Moses Marx
---------------------------
MOSES MARX
UNITED EQUITIES (COMMODITIES) COMPANY
By: /s/ Moses Marx
-------------------------
Moses Marx, General Partner
MOMAR CORP.
By: /s/ Moses Marx
-------------------------
Moses Marx, President
Page 7 of 7 Pages
